Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica R Gilbert

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Human Brain Mapping|April 28, 2026
Selective Modulation of Evidence Accumulation by Hippocampal Theta Oscillations During Mnemonic Decision-MakingPei L Robins, Jessica R Gilbert, Bruce Luber, et al.
Journal of Affective Disorders|May 21, 2025
Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depressionMina Kheirkhah, Nadia S Hejazi, Allison C Nugent, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Clinical and electrophysiological correlates of hopelessness in the context of suicide risk<sup>✰</sup>Elizabeth D Ballard, Roshni P Nischal, Courtney R Burton, et al.
Psychiatry Research. Neuroimaging|April 4, 2026
Attentional bias to death-related stimuli: Modeling cortical dynamics underlying suicide riskYoojin Lee, Jessica R Gilbert, Steven J Lamontagne, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Clinical Pharmacology and Therapeutics|July 26, 2024
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy VolunteersShruti M Raja, Jeffrey T Guptill, Michelle Mack, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Human Brain Mapping|April 28, 2026
Selective Modulation of Evidence Accumulation by Hippocampal Theta Oscillations During Mnemonic Decision-MakingPei L Robins, Jessica R Gilbert, Bruce Luber, et al.
Journal of Affective Disorders|May 21, 2025
Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depressionMina Kheirkhah, Nadia S Hejazi, Allison C Nugent, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2024
Clinical and electrophysiological correlates of hopelessness in the context of suicide risk<sup>✰</sup>Elizabeth D Ballard, Roshni P Nischal, Courtney R Burton, et al.
Psychiatry Research. Neuroimaging|April 4, 2026
Attentional bias to death-related stimuli: Modeling cortical dynamics underlying suicide riskYoojin Lee, Jessica R Gilbert, Steven J Lamontagne, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Clinical Pharmacology and Therapeutics|July 26, 2024
A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy VolunteersShruti M Raja, Jeffrey T Guptill, Michelle Mack, et al.
Pageof 4